Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 190,380,544
  • Shares Outstanding, K 1,737,683
  • Annual Sales, $ 44,328 M
  • Annual Income, $ 6,524 M
  • EBIT $ 9,735 M
  • EBITDA $ 12,851 M
  • 60-Month Beta 0.74
  • Price/Sales 4.35
  • Price/Cash Flow 15.88
  • Price/Book 3.66

Options Overview Details

View History
  • Implied Volatility 28.47% (-2.60%)
  • Historical Volatility 21.22%
  • IV Percentile 96%
  • IV Rank 45.04%
  • IV High 42.50% on 04/07/25
  • IV Low 16.97% on 08/12/25
  • Expected Move (DTE 4) 2.47 (2.20%)
  • Put/Call Vol Ratio 0.34
  • Today's Volume 7,445
  • Volume Avg (30-Day) 17,323
  • Put/Call OI Ratio 0.95
  • Today's Open Interest 168,519
  • Open Int (30-Day) 181,345
  • Expected Range 109.44 to 114.37

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 1.15
  • Number of Estimates 9
  • High Estimate 1.17
  • Low Estimate 1.13
  • Prior Year 1.09
  • Growth Rate Est. (year over year) +5.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
108.34 +3.95%
on 03/06/26
116.82 -3.59%
on 02/27/26
+1.55 (+1.40%)
since 02/09/26
3-Month
105.27 +6.98%
on 01/28/26
129.64 -13.13%
on 12/15/25
-8.63 (-7.12%)
since 12/09/25
52-Week
105.27 +6.98%
on 01/28/26
139.15 -19.07%
on 03/10/25
-24.52 (-17.88%)
since 03/07/25

Most Recent Stories

More News
2 Profitable Stocks on Our Watchlist and 1 We Avoid

2 Profitable Stocks on Our Watchlist and 1 We Avoid

AMAT : 339.31 (+4.49%)
ABT : 112.60 (+2.77%)
CCL : 26.33 (+2.09%)
2 Reasons to Like ABT and 1 to Stay Skeptical

2 Reasons to Like ABT and 1 to Stay Skeptical

ABT : 112.60 (+2.77%)
Is Medtronic Stock Underperforming the S&P 500?

Medtronic has underperformed the S&P 500 over the past year. However, Wall Street analysts remain moderately optimistic about its prospects.

ABT : 112.60 (+2.77%)
$SPX : 6,784.64 (+0.66%)
MDT : 91.34 (+0.48%)
Is Boston Scientific Stock Underperforming the Dow?

Boston Scientific’s shares are trailing the broader market, yet analysts remain optimistic, signaling confidence in longer-term recovery potential.

ABT : 112.60 (+2.77%)
BSX : 71.77 (+0.59%)
$DOWI : 47,745.14 (+0.51%)
Is Abbott Laboratories Stock Underperforming the Nasdaq?

Abbott Laboratories has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.

ABT : 112.60 (+2.77%)
$NASX : 22,657.98 (+1.21%)
BSX : 71.77 (+0.59%)
Exact Sciences Stockholders Approve Acquisition by Abbott

Exact Sciences Corporation (NASDAQ: EXAS) (“Exact Sciences”), a leading provider of cancer screening and diagnostic tests, today announced that its stockholders voted to approve the proposed acquisition...

ABT : 112.60 (+2.77%)
EXAS : 103.71 (+0.20%)
Abbott declares 409th consecutive quarterly dividend

ABBOTT PARK, Ill. , Feb. 20, 2026 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 63 cents per share.

ABT : 112.60 (+2.77%)
3 Large-Cap Stocks with Solid Fundamentals

3 Large-Cap Stocks with Solid Fundamentals

PYPL : 45.92 (-2.24%)
ABT : 112.60 (+2.77%)
ELV : 280.67 (-3.10%)
2 of Wall Street’s Favorite Stocks with Competitive Advantages and 1 We Turn Down

2 of Wall Street’s Favorite Stocks with Competitive Advantages and 1 We Turn Down

LOVE : 11.25 (-5.46%)
ABT : 112.60 (+2.77%)
ELF : 77.15 (-6.42%)
1 Cash-Producing Stock to Keep an Eye On and 2 We Find Risky

1 Cash-Producing Stock to Keep an Eye On and 2 We Find Risky

LMT : 664.28 (-1.11%)
ABT : 112.60 (+2.77%)
CNXN : 60.32 (-0.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures...

See More

Key Turning Points

3rd Resistance Point 113.12
2nd Resistance Point 111.92
1st Resistance Point 110.74
Last Price 112.60
1st Support Level 108.36
2nd Support Level 107.16
3rd Support Level 105.98

See More

52-Week High 139.15
Fibonacci 61.8% 126.21
Fibonacci 50% 122.21
Fibonacci 38.2% 118.21
Last Price 112.60
52-Week Low 105.27

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar